Swedish Medical Products Agency grants approval for clinical study of new stem cell based Parkinson’s Disease treatment
Läkemedelsverket godkänner klinisk fas 1- och fas2a-studie för ny stamcellsbaserad behandling av Parkinsons sjukdom An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval of the trial has already been obtained from the Swedish Ethics Review Authority, and the STEM-PD team, l